FDA Acting CDER Director Jacqueline Corrigan-Curay to Retire in July Amid Mounting Senior Staff Departures

Jacqueline Corrigan-Curay, the acting director of the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA), has announced her retirement effective July 2025. Corrigan-Curay has served at the agency for more than eight years and her departure comes amid a growing number of senior staff exits from the FDA. The cumulative loss of expertise within the agency has been noted as substantial, reflecting ongoing leadership changes in the FDA’s drug regulatory division.